Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1350 of 1631 entries
View as:

Sun Protection Factor Assay (SPF Assay 202/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02930785 Org: User:
Start: 10/12/16 End: 10/27/16 Due: 10/27/17

A Trial to Learn How Much Rivaroxaban Gets Into the Blood When Taken in Different Forms and How Safe They Are in Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT04727021 Org: User:
Start: 07/04/17 End: 10/27/17 Due: 10/27/18

Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670

Phase: N/A Priority: Normal
NCT ID: NCT01816815 Org: User:
Start: 11/30/11 End: 01/31/13 Due: 01/31/14

A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03404726 Org: User:
Start: 03/29/18 End: 01/26/21 Due: 01/26/22

Aprotinin US Special Access Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00611845 Org: User:
Start: - End: - Due: -

Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT02465814 Org: User:
Start: 06/30/15 End: 10/31/16 Due: 10/31/17

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05703880 Org: User:
Start: 06/01/23 End: 10/01/24 Due: 10/01/25

An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden

Phase: N/A Priority: Normal
NCT ID: NCT06053749 Org: User:
Start: 03/20/24 End: 03/31/26 Due: 03/31/27

An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health

Phase: N/A Priority: Normal
NCT ID: NCT05477953 Org: User:
Start: 06/30/25 End: 01/31/32 Due: 01/31/33

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT05348876 Org: User:
Start: 08/03/22 End: 01/28/26 Due: 01/28/27

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01460537 Org: User:
Start: 11/18/11 End: 12/18/15 Due: 12/18/16

Pharmacokinetics and Safety of Vilaprisan in Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03411980 Org: User:
Start: 02/02/18 End: 02/06/19 Due: 02/06/20

A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03215511 Org: User:
Start: 07/03/17 End: 01/30/23 Due: 01/30/24

An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China

Phase: N/A Priority: Normal
NCT ID: NCT05728502 Org: User:
Start: 04/25/23 End: 12/31/25 Due: 12/31/26

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Phase: N/A Priority: Normal
NCT ID: NCT00102141 Org: User:
Start: 04/30/04 End: 07/31/05 Due: 07/31/06

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

Phase: N/A Priority: Normal
NCT ID: NCT01257984 Org: User:
Start: 12/31/10 End: 09/30/12 Due: 09/30/13

A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years.

Phase: N/A Priority: Normal
NCT ID: NCT05028608 Org: User:
Start: 09/06/21 End: 01/20/22 Due: 01/20/23

Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT02825160 Org: User:
Start: 08/01/16 End: 09/27/23 Due: 09/27/24

Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116

Phase: N/A Priority: Normal
NCT ID: NCT03119077 Org: User:
Start: 04/27/17 End: 01/31/18 Due: 01/31/19

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose

Phase: N/A Priority: Normal
NCT ID: NCT03602339 Org: User:
Start: 11/14/18 End: 05/26/20 Due: 05/26/21

Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI

Phase: N/A Priority: Normal
NCT ID: NCT00934882 Org: User:
Start: 08/31/09 End: 04/30/12 Due: 04/30/13

Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels

Phase: N/A Priority: Normal
NCT ID: NCT04097912 Org: User:
Start: 09/30/19 End: 11/15/20 Due: 11/15/21

Russia/Ukraine Suppression of Ovarian Activity Study

Phase: N/A Priority: Normal
NCT ID: NCT02550977 Org: User:
Start: 09/18/15 End: 08/15/16 Due: 08/15/17

Greatest International Antiinfective Trial With Avelox

Phase: N/A Priority: Normal
NCT ID: NCT00932802 Org: User:
Start: 02/29/04 End: 11/30/07 Due: 11/30/08

Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT00640315 Org: User:
Start: 08/31/08 End: 09/30/09 Due: 09/30/10